Resources Investment Advisors, Llc. Arrowhead Pharmaceuticals, Inc. Transaction History

Resources Investment Advisors, Llc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$26.26 - $34.86 $10,504 - $13,944	-400 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$17.43 - $28.82 $6,972 - $11,528	400 New	400 $0
Q1 2019 May 10, 2019	SELL	$12.05 - $20.18 $12,592 - $21,088	-1,045 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$10.74 - $19.7 $11,223 - $20,586	1,045 New	1,045 $13,000
Q3 2018 Nov 07, 2018	SELL	$14.0 - $20.3 $7,000 - $10,150	-500 Closed	0 $0

Q2 2018 Aug 15, 2018	BUY	$6.37 - $14.02 $3,185 - $7,010	500 New	500 $7,000
Q3 2017 Nov 13, 2017	SELL	$1.69 - $4.33 $2,019 - $5,174	-1,195 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	1,195	1,195 $2,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

Stay updated on Resources Investment Advisors, Llc. with notifications on news.